Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Patricia Lemarchand

University Name

France

This profile is automatically generated from trusted academic sources.

Google Scholar

.

ORCID

.

LinkedIn

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI

Contact this professor

LinkedIn

Google Scholar

Research Interests

Cell Biology

60%

Tissue Engineering

70%

Stem Cell Biology

50%

Genome Engineering

40%

Cardiovascular Biology

40%

Assisted Reproductive Technology

30%

Ischemic Physiology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant trajectory

Year:

2025

Questioning the Relevance of Sex Categories implemented in Medical Decision Support Systems - The Example of Pulmonary Function

Year:

2024

Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarction

Year:

2023

Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarction

Year:

2023

Generation of human induced pluripotent stem cell lines from four unrelated healthy control donors carrying European genetic background

Year:

2022

Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene

Year:

2022

Deciphering Transcriptional Networks during Human Cardiac Development

Year:

2022

Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene

Year:

2022

Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia.

Year:

2022

Generation of human induced pluripotent stem cell lines from four unrelated healthy control donors carrying European genetic background

Year:

2022

Generation of human induced pluripotent stem cell lines from two patients affected by catecholamine-induced QT prolongation (CIQTP)

Year:

2022

Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system

Year:

2022

Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia

Year:

2022

A consistent arrhythmogenic trait in Brugada syndrome cellular phenotype

Year:

2021

Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes

Year:

2020

Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells

Year:

2020

Collaborators6

Flavien Charpentier

Université de Nantes

FRANCE

Gildas Loussouarn

Université de Nantes

FRANCE

Jean Baptiste Gourraud

Professor

-

FRANCE

Amandine Caillaud

Université de Nantes

FRANCE

Isabelle Baró

-

FRANCE

FX Blanc

Professor of Respiratory Medicine

Université de Nantes

FRANCE

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI